Inicio › Esquizofrenia › Georgia
Ensayos clínicos de Esquizofrenia en Georgia
29 estudios sobre Esquizofrenia buscan participantes en Georgia.
Ciudades en Georgia
Texto oficial del estudio (inglés)
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Atlanta Center for Medical Research, Atlanta
- Local Institution - 0070, Sandy Springs
- Local Institution - 0189, Savannah
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 28 sept 2026 · NCT07686263A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Synexus Clinical Research US Inc, Atlanta
ReclutandoFase 1
Edades de 18 a 55 · Todos los sexos · Actualizado el 28 sept 2026 · NCT07615426Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07227818NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Decatur
- y 1 más
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07114874Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- CenExeli Research LLC, Atlanta
- Atlanta Center for Medical Research, Atlanta
- CenExeli Research LLC 1, Savannah
ReclutandoFase 3
Edades de 5 a 17 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06229210A Study of Brenipatide in Adult Participants With Schizophrenia
- Atlanta Center for Medical Research, Atlanta
- Augusta University, Augusta
ReclutandoFase 2
Edades de 18 a 55 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07410507A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Atlanta Center for Medical Research, Atlanta
- Salveo Integrative Health - Lawrenceville, Lawrenceville
- Denali Health Atlanta, LLC, Stone Mountain
ReclutandoFase 3
Edades de 5 a 17 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07424404A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Augusta
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- CenExel iResearch, LLC, Decatur
ReclutandoFase 1
Edades de 18 a 55 · Todos los sexos · Actualizado el 17 sept 2026 · NCT0773449352-week Open Label Safety-Tolerability Study
- CenExel, Atlanta
- Accelerated Clinical Trial, Snellville
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 9 sept 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Atlanta Center for Medical Research, Atlanta
- Salveo Integrative Health - Lawrenceville, Lawrenceville
- Denali Health Atlanta, LLC, Stone Mountain
ReclutandoFase 3
Edades de 13 a 17 · Todos los sexos · Actualizado el 4 sept 2026 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Atlanta Center for Medical Research, Atlanta
- CenExel iResearch, LLC, Decatur
ReclutandoFase 1
Edades de 18 a 55 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Atlanta
- Clinical Site, Decatur
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 1 sept 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Emory University., Atlanta
- Local Institution - 0049, Austell
- Local Institution - 0044, Marietta
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Decatur
ReclutandoFase 3
Edades de 10 a 17 · Todos los sexos · Actualizado el 14 ago 2026 · NCT05303064Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- Bioxcel Clinical Research Site, Decatur
ReclutandoFase 1
Edades de 10 a 17 · Todos los sexos · Actualizado el 11 ago 2026 · NCT05025605Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- CenExel iResearch, Decatur
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 29 jul 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Accelerated Clinical Trial, Snellville
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07363577A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Cenexel ACMR, Atlanta
- Cenexel iResearch Atlanta, Decatur
ReclutandoFase 2
Edades de 18 a 55 · Todos los sexos · Actualizado el 23 jun 2026 · NCT07191483Anti-Inflammatory Challenge in Schizophrenia
- Grady Memorial Hospital, Atlanta
- Emory University Hospital, Atlanta
ReclutandoFase 4
Edades de 18 a 55 · Todos los sexos · Actualizado el 3 jun 2026 · NCT05823532CLOZAPINE Response in Biotype-1
- University of Georgia, Athens
ReclutandoFase 4
Edades de 18 a 60 · Todos los sexos · Actualizado el 11 may 2026 · NCT04580134Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- Augusta University Research Institute, Inc., Augusta
ReclutandoFase 4
Edades de 18 a 65 · Todos los sexos · Actualizado el 4 may 2026 · NCT05208190Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Georgia, Athens
ReclutandoEstudio observacional
Edades de 18 a 40 · Todos los sexos · Actualizado el 10 mar 2026 · NCT06740383NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Decatur
- Neurocrine Clinical Site, Snellville
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 6 mar 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Peachtree Corners
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 12 ene 2026 · NCT06961968Study of ALTO-101 in Patients With Schizophrenia
- Site 5064, Snellville
ReclutandoFase 2
Edades de 21 a 55 · Todos los sexos · Actualizado el 26 dic 2025 · NCT06502964Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Decatur
ReclutandoFase 4
Edades de 12 a 17 · Todos los sexos · Actualizado el 4 mar 2025 · NCT05648591Cognitive Training for Emotion Regulation in Psychotic Disorders
- University of Georgia, Athens
Reclutando
Edades de 18 a 60 · Todos los sexos · Actualizado el 5 feb 2025 · NCT04414215Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Atlanta
- Reviva site, Decatur
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 18 a 65 · Todos los sexos · Actualizado el 19 dic 2024 · NCT05184335De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.